Stay updated on Atezolizumab with BCG in NMIBC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.

Latest updates to the Atezolizumab with BCG in NMIBC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a Phase Ib/II study on atezolizumab for bladder cancer, which included safety, dosing, and eligibility criteria. Additionally, a new revision number has been added, indicating an update to the document version.SummaryDifference27%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to Atezolizumab with BCG in NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.